Sansone Francesco, Attanasi Marina, Di Filippo Paola, Sferrazza Papa Giuseppe Francesco, Di Pillo Sabrina, Chiarelli Francesco
Paediatric Allergy and Pulmonology Unit, Department of Paediatrics, University of Chieti-Pescara, 66100 Chieti, Italy.
Dipartimento di Scienze della Salute, Università degli Studi di Milano, 20146 Milan, Italy.
Diagnostics (Basel). 2021 Sep 28;11(10):1783. doi: 10.3390/diagnostics11101783.
Respiratory infection diseases are among the major causes of morbidity and mortality in children. Diagnosis is focused on clinical presentation, yet signs and symptoms are not specific and there is a need for new non-radiating diagnostic tools. Among these, lung ultrasound (LUS) has recently been included in point-of-care protocols showing interesting results. In comparison to other imaging techniques, such as chest X-ray and computed tomography, ultrasonography does not use ionizing radiations. Therefore, it is particularly suitable for clinical follow-up of paediatric patients. LUS requires only 5-10 min and allows physicians to make quick decisions about the patient's management. Nowadays, LUS has become an early diagnostic tool to detect pneumonia during the COVID-19 pandemic. In this narrative review, we show the most recent scientific literature about advantages and limits of LUS performance in children. Furthermore, we discuss the major paediatric indications separately, with a paragraph fully dedicated to COVID-19. Finally, we mention potential future perspectives about LUS application in paediatric respiratory diseases.
呼吸道感染疾病是儿童发病和死亡的主要原因之一。诊断主要基于临床表现,但症状和体征并不具有特异性,因此需要新的无辐射诊断工具。其中,肺部超声(LUS)最近已被纳入床旁诊断方案,并显示出有趣的结果。与其他成像技术如胸部X线和计算机断层扫描相比,超声检查不使用电离辐射。因此,它特别适合儿科患者的临床随访。LUS仅需5-10分钟,医生可以据此对患者的治疗做出快速决策。如今,LUS已成为在COVID-19大流行期间检测肺炎的早期诊断工具。在这篇叙述性综述中,我们展示了关于LUS在儿童中应用的优势和局限性的最新科学文献。此外,我们分别讨论了主要的儿科适应症,并专门用一段内容论述了COVID-19。最后,我们提到了LUS在儿科呼吸道疾病中应用的潜在未来前景。